betaxolol has been researched along with Arrhythmia in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized double-blind trial was performed with betaxolol, a beta 1-selective and long-acting beta-blocker, in patients with a recent first uncomplicated acute myocardial infarction (AMI)." | 9.06 | Effects of betaxolol on heart rate in patients with a recent transmural myocardial infarction. ( Coupez, R; De Geest, H; Ector, H; Kesteloot, H; Yang, XS, 1987) |
| "Antiarrhythmic effects of a new beta 1 selective adrenoceptor blocker, betaxolol, were examined in comparison with those of atenolol using two canine ventricular arrhythmia models (adrenaline arrhythmia and digitalis arrhythmia)." | 7.67 | Effects of betaxolol, a new beta 1 selective blocker, on canine ventricular arrhythmias. ( Akiyama, K; Hashimoto, K; Mitsuhashi, H, 1987) |
| "A randomized double-blind trial was performed with betaxolol, a beta 1-selective and long-acting beta-blocker, in patients with a recent first uncomplicated acute myocardial infarction (AMI)." | 5.06 | Effects of betaxolol on heart rate in patients with a recent transmural myocardial infarction. ( Coupez, R; De Geest, H; Ector, H; Kesteloot, H; Yang, XS, 1987) |
| "Antiarrhythmic effects of a new beta 1 selective adrenoceptor blocker, betaxolol, were examined in comparison with those of atenolol using two canine ventricular arrhythmia models (adrenaline arrhythmia and digitalis arrhythmia)." | 3.67 | Effects of betaxolol, a new beta 1 selective blocker, on canine ventricular arrhythmias. ( Akiyama, K; Hashimoto, K; Mitsuhashi, H, 1987) |
| "Betaxolol has been proven to be a safe and effective antihypertensive agent, and was recently approved for clinical use in the United States for this indication." | 2.67 | Betaxolol: a new long-acting beta 1-selective adrenergic blocker. ( Behrman, D; Frishman, WH; Lazar, EJ; Tepper, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frishman, WH | 1 |
| Tepper, D | 1 |
| Lazar, EJ | 1 |
| Behrman, D | 1 |
| Fillette, F | 1 |
| Lebrun, S | 1 |
| Malkawi, K | 1 |
| Mitsuhashi, H | 1 |
| Akiyama, K | 1 |
| Hashimoto, K | 1 |
| Yang, XS | 1 |
| Coupez, R | 1 |
| Ector, H | 1 |
| Kesteloot, H | 1 |
| De Geest, H | 1 |
2 trials available for betaxolol and Arrhythmia
| Article | Year |
|---|---|
Betaxolol: a new long-acting beta 1-selective adrenergic blocker.
Topics: Adult; Arrhythmias, Cardiac; Betaxolol; Biological Availability; Blood Pressure; Clinical Trials as | 1990 |
Effects of betaxolol on heart rate in patients with a recent transmural myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Betaxolol; Double-Blind Method; Female; Hea | 1987 |
2 other studies available for betaxolol and Arrhythmia
| Article | Year |
|---|---|
[Action of betaxolol on ventricular arrhythmias. Control of efficacy and tolerance by repetitive Holter recordings].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Betaxolol; Electrocardiography; Fema | 1985 |
Effects of betaxolol, a new beta 1 selective blocker, on canine ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Betaxo | 1987 |